The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis

Published:2010-12-01 Issue:12 Volume:100 Page:808
ISSN:2078-5135
Container-title:South African Medical Journal
language:
Short-container-title:S Afr Med J

Author:

Abdool Karim Quarraisha,Abdool Karim Salim S,Baxter Cheryl,Friedland Gerald,Gengiah Tanuja,Gray Andrew,Grobler Anneke,Naidoo Kogileum,Padayatchi Nesri,El-Sadr Wafaa

Publisher

South African Medical Association NPC

Subject

General Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers to and enablers of uptake of antiretroviral therapy in integrated HIV and tuberculosis treatment programmes in sub-Saharan Africa: a systematic review and meta-analysis;AIDS Research and Therapy;2021-11-16

2. 90-90-90 HIV targets;Current Opinion in HIV and AIDS;2018-11

3. Two diseases, same person: moving toward a combined HIV and tuberculosis continuum of care;International Journal of STD & AIDS;2018-04-08

4. CAPRISA 003: Timing of Antiretroviral Initiation in HIV-TB Co-infected Patients—The SAPiT Trial;The CAPRISA Clinical Trials: HIV Treatment and Prevention;2017

5. Predictors and Timing of ATT Initiation among HIV-TB Patients at ART Centers of Karnataka, India: Two Year Follow-Up;PLOS ONE;2015-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP